These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16421770)

  • 1. The epidemiology of Kawasaki disease in an urban hospital: does African American race protect against coronary artery aneurysms?
    Porcalla AR; Sable CA; Patel KM; Martin GR; Singh N
    Pediatr Cardiol; 2005; 26(6):775-81. PubMed ID: 16421770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and Risk Factors for Giant Coronary Artery Aneurysms Identified After Acute Kawasaki Disease.
    Masuda H; Ae R; Koshimizu TA; Matsumura M; Kosami K; Hayashida K; Makino N; Matsubara Y; Sasahara T; Nakamura Y
    Pediatr Cardiol; 2021 Apr; 42(4):969-977. PubMed ID: 33682062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA.
    Okubo Y; Nochioka K; Sakakibara H; Testa M; Sundel RP
    Clin Rheumatol; 2017 Feb; 36(2):413-419. PubMed ID: 27987089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease.
    Sabharwal T; Manlhiot C; Benseler SM; Tyrrell PN; Chahal N; Yeung RS; McCrindle BW
    Am J Cardiol; 2009 Dec; 104(12):1743-7. PubMed ID: 19962487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and clinical features of Kawasaki disease in Spain over 5 years and risk factors for aneurysm development. (2011-2016): KAWA-RACE study group.
    Fernandez-Cooke E; Barrios Tascón A; Sánchez-Manubens J; Antón J; Grasa Lozano CD; Aracil Santos J; Villalobos Pinto E; Clemente Garulo D; Mercader Rodríguez B; Bustillo Alonso M; Nuñez Cuadros E; Navarro Gómez ML; Domínguez-Rodríguez S; Calvo C;
    PLoS One; 2019; 14(5):e0215665. PubMed ID: 31107862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki Disease Outcomes and Response to Therapy in a Multiethnic Community: A 10-Year Experience.
    Skochko SM; Jain S; Sun X; Sivilay N; Kanegaye JT; Pancheri J; Shimizu C; Sheets R; Tremoulet AH; Burns JC
    J Pediatr; 2018 Dec; 203():408-415.e3. PubMed ID: 30268398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
    Platt B; Belarski E; Manaloor J; Ofner S; Carroll AE; John CC; Wood JB
    JAMA Netw Open; 2020 Jan; 3(1):e1918565. PubMed ID: 31899532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A registry study of Kawasaki disease patients with coronary artery aneurysms (KIDCAR): a report on a multicenter prospective registry study three years after commencement.
    Koyama Y; Miura M; Kobayashi T; Hokosaki T; Suganuma E; Numano F; Furuno K; Shiono J; Ebata R; Fuse S; Fukazawa R; Mitani Y
    Eur J Pediatr; 2023 Feb; 182(2):633-640. PubMed ID: 36434403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D; Yeo Y; Ha K; Jang G; Lee J; Lee K; Son C; Lee J
    Eur J Pediatr; 2009 Nov; 168(11):1315-21. PubMed ID: 19159953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology, clinical characteristics, and immediate outcome of Kawasaki disease: a population-based study from a tropical country.
    Mat Bah MN; Alias EY; Razak H; Sapian MH; Foo FH; Abdullah N
    Eur J Pediatr; 2021 Aug; 180(8):2599-2606. PubMed ID: 34086103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Model Development and Validation for Prediction of Coronary Artery Aneurysms in Kawasaki Disease in a North American Population.
    Son MBF; Gauvreau K; Tremoulet AH; Lo M; Baker AL; de Ferranti S; Dedeoglu F; Sundel RP; Friedman KG; Burns JC; Newburger JW
    J Am Heart Assoc; 2019 Jun; 8(11):e011319. PubMed ID: 31130036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience.
    Maric LS; Knezovic I; Papic N; Mise B; Roglic S; Markovinovic L; Tesovic G
    Rheumatol Int; 2015 Jun; 35(6):1053-8. PubMed ID: 25429794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study.
    Berdej-Szczot E; Firek-Pędras M; Szydłowski L; Krzystolik-Ładzińska J; Klimek K; Małecka-Tendera E
    Kardiol Pol; 2013; 71(12):1279-86. PubMed ID: 23990228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between GRIN3A gene polymorphism in Kawasaki disease and coronary artery aneurysms in Taiwanese children.
    Lin YJ; Chang JS; Liu X; Hung CH; Lin TH; Huang SM; Jeang KT; Chen CY; Liao CC; Lin CW; Lai CH; Tien N; Lan YC; Ho MW; Chien WK; Chen JH; Huang YC; Tsang H; Wu JY; Chen CH; Chang LC; Tsai FJ
    PLoS One; 2013; 8(11):e81384. PubMed ID: 24278430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paediatric overdiagnosis modelled by coronary abnormality trends in Kawasaki disease.
    Coon ER; Wilkes J; Bratton SL; Srivastava R
    Arch Dis Child; 2018 Oct; 103(10):937-941. PubMed ID: 29472194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines.
    Ghelani SJ; Sable C; Wiedermann BL; Spurney CF
    Pediatr Cardiol; 2012 Oct; 33(7):1097-103. PubMed ID: 22349679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors and implications of progressive coronary dilatation in children with Kawasaki disease.
    Liu MY; Liu HM; Wu CH; Chang CH; Huang GJ; Chen CA; Chiu SN; Lu CW; Lin MT; Chang LY; Wang JK; Wu MH
    BMC Pediatr; 2017 Jun; 17(1):139. PubMed ID: 28587647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.